TuesdayFeb 16, 2021 11:23 am

Sharing Services Global Corp. (SHRG) Promotes Elevated Customer-Centric Model

Customers seek out highly personalized buying experiences in 2020 and beyond. Companies looking at what it means to be customer centric, how to create long-lasting relationships. Highly personalized customer service has always been high priority for SHRG. As a new year begins, direct-selling leaders are looking to the future and wondering what trends will stick following the COVID-19 pandemic. Industry experts predict that companies with a strong customer-centric focus will perform the best moving forward, a prediction that bodes well for Sharing Services Global Corporation (OTCQB: SHRG). Sharing Services is committed to elevating the convenience and value of doing business…

Continue Reading

TuesdayFeb 16, 2021 11:13 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Microcap Rodeo Winter Wonderland Conference

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that it will present at the upcoming Microcap Rodeo Winter Wonderland Conference. The virtual conference is slated for Feb. 16–19, 2021. AzurRx CEO James Sapirstein is scheduled to make a live company presentation during the conference. The AzurRx presentation is scheduled for 4:30 p.m. ET on Feb. 17. During the presentation, Sapirstein will provide an overview of AzurRx’s business and clinical development programs; he will also talk about milestones anticipated throughout the coming year. Following the presentation, Sapirstein and other AzurRx executives will be…

Continue Reading

TuesdayFeb 16, 2021 11:04 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Completion of European CE-IVD Application for 25-Minute COVID-19 RT-PCR Test

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) has made a significant announcement, along with its exclusive German diagnostics development partner, 3a-diagnostics GmbH ("3a"). The companies have completed all actions and procedures required for the European regulatory application for the rapid point-of-care SARS-CoV-2 (COVID-19) RT-PCR Test System. The announcement noted that ISO 13485 approval for 3a as a medical device manufacturer is expected in the next few weeks; 3a also anticipates European regulatory approval as a commercial in vitro diagnostic device (CE-IVD) for COVID-ID Lab by early March. The exclusive lab is designed to be a rapid, accurate and robust test…

Continue Reading

TuesdayFeb 16, 2021 10:42 am

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Announces Packaging Revisions Project Completion, Positive Q1 2021 Expectations

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has noted that a Q4 project involving a redesign of Bidi(R) Vapor LLC’s packaging and labeling for its entire product line has been completed. The redesign decision was made as the Bidi company opted to meet and exceed the FDA’s proposed guidelines for all of its product, which meant the company halted production of its products until the project was finished. Kaival is the exclusive global distributor of all products manufactured by Bidi Vapor, including the Bidi(R) Stick,…

Continue Reading

TuesdayFeb 16, 2021 10:33 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) Strengths, Milestones Featured as CBD Industry Projected to See Impressive Growth

HempFusion Wellness (TSX: CBD.U), along with its five-channel strategy, impressive line of products and historic first day of trading after completing its $17 million IPO, were the focus of a recent article. The article outlined the power of the company, noting that it was the first U.S.-based CBD company approved for listing directly on the TSX. The article recounted the company’s strength as a leader in the health and wellness CBD industry and called out its diverse portfolio of brands, including HempFusion CBD, Probulin Probiotics, Biome Research and HF Labs; the article also noted that the company offers four dozen…

Continue Reading

TuesdayFeb 16, 2021 9:56 am

QualityStocksNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Issues Operational Update

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today announced that the impact of the ongoing polar vortex in the American southwest is likely to increase operational costs during the first quarter of 2021. According to the update, the company's current energy contract is backed by natural gas. Weather conditions in the southwest United States have impacted natural gas production and transport, leading to record high prices since Friday, Feb. 12, with unit costs increasing from US$3.00 to over US$300 per mmBtu. The temporary increase in prices is expected to be short term and impacts energy costs at the…

Continue Reading

TuesdayFeb 16, 2021 9:26 am

QualityStocksNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Announces Availability of Flagship Product Through Online Website

TAAT(TM) Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has announced that, effective Wednesday, Feb. 18, at 9 a.m. ET, its ecommerce portal will be live and operational, with smokers in the United States aged 21 years of age and older being able to purchase the company’s flagship product — TAAT(TM) Original, Smooth and Menthol — by the carton in certain areas. The product is currently available for retail sale throughout the state of Ohio. In the announcement, the company noted that it believed that selling its product online would accelerate its entry into new markets across the country. The…

Continue Reading

FridayFeb 12, 2021 3:20 pm

CNS Pharmaceuticals (NASDAQ: CNSP) Celebrates IND Status, Prepares to Launch Brain Cancer Drug Trials

Brain cancer drug developer CNS Pharmaceuticals is celebrating recent news that the U.S. Food and Drug Administration (“FDA”) granted investigational new drug (“IND”) status to CNS Pharmaceuticals’ leading candidate for fighting glioblastomas Glioblastomas are a class of aggressive brain cancers with no known cure and a median life expectancy of 14 to 16 months following diagnosis The FDA’s decision to grant CNSP’s request for IND status clears the way for the company to begin human clinical trials within the next couple of months The company’s sublicensee partner, WPD Pharmaceuticals, will also prepare a first-ever Phase I trial for drug safety…

Continue Reading

FridayFeb 12, 2021 3:07 pm

Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) Builds Momentum in its PowerTap Investment as Andretti Agreement Takes Off

Canada’s Clean Power Capital Corp., a holding company focused on investing in the renewable energy sector, recently increased its equity interest in California’s PowerTap Hydrogen Fueling Corp. from 90 percent to 94.5 percent PowerTap inked an agreement last month with the companies collectively comprising the Andretti Group, operated by auto racing legends Mario and Michael Andretti to situate and market PowerTap’s hydrogen fueling technology PowerTap followed up on the agreement by appointing Michael Andretti to the company board PowerTap recently announced the strategy behind its business model, focusing on profit motivations for the retail locations where the fueling stations will…

Continue Reading

FridayFeb 12, 2021 2:53 pm

Grapefruit USA Inc. (GPFT) Rolls Out Hourglass by Grapefruit in Greater Los Angeles; Poised to Sustain Rapid Growth

Grapefruit expands availability of patented Hourglass by Grapefruit(TM) product to Greater Los Angeles area Hourglass is manufactured only at Grapefruit's Coachillin facility, available only through Grapefruit authorized retailers GPFT achieved robust growth in 2020, poised to continue momentum going forward as demand remains strong Grapefruit USA (OTCQB: GPFT), a premier fully licensed California-based company, has announced that its patented Hourglass time-release THC+Cannabinoid infused topical delivery cream has been rolled out to additional licensed retail cannabis locations in the Greater Los Angeles area (https://ibn.fm/ZohgC). Hourglass is manufactured exclusively at Grapefruit's Coachillin facility and available only through Grapefruit authorized retailers. The company…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered